Ketoconazole and Epicondylitis - a phase IV clinical study of FDA data


Epicondylitis is reported only by a few people who take Ketoconazole.

The phase IV clinical study analyzes which people take Ketoconazole and have Epicondylitis. It is created by eHealthMe based on reports of 12,372 people who have side effects while taking Ketoconazole from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 25, 2022

12,372 people reported to have side effects when taking Ketoconazole.
Among them, 4 people (0.03%) have Epicondylitis.

What is Ketoconazole?

Ketoconazole has active ingredients of ketoconazole. It is often used in fungal infection. eHealthMe is studying from 12,621 Ketoconazole users for its effectiveness, alternative drugs and more.

What is Epicondylitis?

Epicondylitis (tennis elbow) is found to be associated with 728 drugs and 395 conditions by eHealthMe.

Number of Ketoconazole and Epicondylitis reports submitted per year:

Could Ketoconazole cause Epicondylitis?

Gender of people who have Epicondylitis when taking Ketoconazole *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Epicondylitis when taking Ketoconazole *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Ketoconazole *:

  1. Dilaudid: 4 people, 100.00%
  2. Amlodipine: 3 people, 75.00%
  3. Morphine: 3 people, 75.00%
  4. Prilosec: 3 people, 75.00%
  5. Ativan: 2 people, 50.00%
  6. Nexavar: 2 people, 50.00%
  7. Norvasc: 2 people, 50.00%
  8. Colcrys: 2 people, 50.00%
  9. Nystop: 2 people, 50.00%
  10. Colace: 2 people, 50.00%

Common side effects people have besides Epicondylitis *:

  1. Abdominal Pain: 4 people, 100.00%
  2. Tooth Abscess (pus formation in tooth): 4 people, 100.00%
  3. Oropharyngeal Pain: 4 people, 100.00%
  4. Nosebleed (bleeding from nose): 4 people, 100.00%
  5. Joint Pain: 4 people, 100.00%
  6. Pain: 4 people, 100.00%
  7. Toothaches (tooth pain): 4 people, 100.00%
  8. Drowsiness: 3 people, 75.00%
  9. Dry Mouth: 3 people, 75.00%
  10. Gingival Bleeding (bleeding gums): 3 people, 75.00%

Common conditions people have *:

  1. Thyroid Cancer: 2 people, 50.00%
  2. High Blood Pressure: 2 people, 50.00%
  3. Trismus (reduced opening of the jaws): 1 person, 25.00%
  4. Multiple Myeloma (cancer of the plasma cells): 1 person, 25.00%
  5. Metastases To Bone (cancer spreads to bone): 1 person, 25.00%
  6. Breast Cancer: 1 person, 25.00%
  7. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 25.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ketoconazole and have Epicondylitis?

Check whether Epicondylitis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Epicondylitis and when was it recovered:

Expand to all the drugs that have ingredients of ketoconazole:

Alternative drugs to, pros and cons of Ketoconazole:

Common Ketoconazole side effects:

Browse all side effects of Ketoconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Epicondylitis treatments and more:

COVID vaccines that are related to Epicondylitis:

Common drugs associated with Epicondylitis:

All the drugs that are associated with Epicondylitis:

Common conditions associated with Epicondylitis:

All the conditions that are associated with Epicondylitis:

How the study uses the data?

The study uses data from the FDA. It is based on ketoconazole (the active ingredients of Ketoconazole) and Ketoconazole (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: